Back
Black Diamond Therapeutics 10K Form
Buy
56
BDTX
Black Diamond Therapeutics
Last Price:
$2.87
Seasonality Move:
-29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BDTX News And Ratings
See the #1 stock for the next 7 days that we like better than BDTX
BDTX Financial Statistics
Sales & Book Value
Annual Sales: | -- |
---|---|
Cash Flow: | $53.4M |
Price / Cash Flow: | 12.58 |
Annual Sales: | $2.50 |
Price / Book: | 1.1 |
Profitability
EPS (TTM): | 0.06000 |
---|---|
Net Income (TTM): | $5.1M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Black Diamond Therapeutics Earnings Forecast
Key Black Diamond Therapeutics Financial Ratios
-
Per Share Earnings over the last 8 years have been positive in 3 years.
Black Diamond Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | BDTX |
CUSIP: | 09203E |
Website: | blackdiamondtherapeutics.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 9.24 |
Quick Ratio: | 9.05 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
BDTX Technical Analysis vs Fundamental Analysis
Buy
56
Black Diamond Therapeutics (BDTX)
is a Buy
Is Black Diamond Therapeutics a Buy or a Sell?
-
Black Diamond Therapeutics stock is rated a BuyThe current Black Diamond Therapeutics [BDTX] share price is $2.74. The Score for BDTX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.